Related Experiment Video
Updated: Mar 23, 2026

A Swine Model of Neonatal Asphyxia
Published on: October 11, 2011
Treatment options for apnoea of prematurity
Sarah U Morton1, Vincent C Smith2
1Harvard Neonatal-Perinatal Fellowship Program, Boston Children's Hospital Boston, Boston, Massachusetts, USA.
Insights
Apnoea of prematurity (AOP) affects extremely preterm infants. Effective treatments, including standard therapies and emerging options, are crucial for optimizing care and preventing negative outcomes in these vulnerable newborns.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
Background:
- Apnoea of prematurity (AOP) is a common condition in infants born before 28 weeks gestation or weighing less than 1000g.
- Untreated AOP can lead to adverse outcomes in preterm infants.
Purpose of the Study:
- To review the pathophysiology of AOP.
- To discuss associated conditions linked to AOP.
- To outline current and emerging treatment options for AOP.
Main Methods:
- Literature review of pathophysiology, associated conditions, and treatments for AOP.
- Synthesis of information on standard therapies (xanthine, respiratory support).
- Inclusion of novel therapeutic approaches like stochastic vibrotactile stimulation and new pharmaceutical agents.
Main Results:
- AOP pathophysiology involves immature respiratory control mechanisms.
- Associated conditions can complicate AOP management.
- A range of treatments exist, from established methods to innovative interventions.
Conclusions:
- Effective management of AOP is vital for improving preterm infant outcomes.
- Standard treatments like xanthine therapy and respiratory support remain important.
- Emerging therapies offer expanded options for AOP treatment.
Abstract:
Apnoea of prematurity (AOP) affects almost all infants born at <28 weeks gestation or with birth weight <1000 g. When untreated, AOP may be associated with negative outcomes. Because of these negative outcomes, effective treatment for AOP is an important part of optimising care of preterm infants. Standard treatment usually involves xanthine therapy and respiratory support. Cutting-edge work with stochastic vibrotactile stimulation and new pharmaceutical agents continues to expand therapeutic options. In this article, we review the pathophysiology of AOP, associated conditions and treatment options.
More Related Videos
04:56Laryngeal Mask Airway LMA Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway SGA
Published on: July 14, 2023
07:15Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Sleep Apnea
The condition is more prevalent among...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...